SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Update

17 Nov 2017 07:02

RNS Number : 8037W
Carillion PLC
17 November 2017
 

17 November 2017

Update on discussions with stakeholders, trading and financial covenants deferral

Carillion plc ("Carillion" or "the Group") today provides an update on discussions with its financial stakeholders, trading and its intention to seek to defer the testing of its financial covenants.

Since July, the Group has been focused on reducing costs, collecting cash, executing its disposals programme and implementing its new operating model. These self-help measures will serve to reduce the Group's average net debt over time, but they will not be sufficient to enable the Group to achieve its target net debt to EBITDA ratio of between 1.0 to 1.5 times by the end of 2018. The Board is therefore in discussions with stakeholders regarding a broad range of options to further reduce net debt and repair and strengthen the Group's balance sheet. This will require some form of recapitalisation, which could involve a restructuring of the balance sheet. The Board expects to commence steps to implement the chosen option during the first quarter of 2018 and a further announcement will be made in due course.

In its interim results on 29 September 2017, Carillion confirmed that it was forecast to be in compliance with its financial covenants as at 31 December 2017. As then indicated, compliance with its financial covenants was dependent on achieving its underlying forecasts, which assume that the normal pattern of receipts and payments continue alongside the completion of a number of PPP disposals and settlement receipts on contracts.

The Board has kept under continuous review the risk that receipts from contract claims and/or disposals forecast to be received during November and December 2017 might slip beyond 31 December 2017. The Group now expects that a combination of delays to certain PPP disposals, a slippage in the commencement date of a significant project in the Middle East and lower than expected margin improvements across a small number of UK Support Services contracts, partially offset by cost savings initiatives realised in the fourth quarter, will lead to profits for the year to 31 December 2017 being materially lower than current market expectations. Given the impact of delays in receipts and disposals, the Group now expects full year average net borrowing in 2017 to be between £875m and £925m.

Based on its latest forecasts, reflecting the items mentioned above, the Board now expects a covenant breach as at 31 December 2017. Following discussions with its principal lenders and with their support, the Board has concluded that it is necessary to amend the relevant agreements to defer the test date for both its financial covenants from 31 December 2017 to 30 April 2018 (based on EBITDA for the 12 months to that date), by which time it expects to be implementing its recapitalisation plan. Carillion has now commenced a process to seek the consents necessary to make this amendment.

Commenting, Interim Chief Executive, Keith Cochrane said:

"Whilst we continue to target cash collections, reduce costs, execute disposals and focus on delivering for our customers, it is clear that significant challenges remain and more needs to be done to reduce net debt and rebuild the balance sheet. Constructive dialogue is continuing with our financial stakeholders, and I am grateful for their support. I remain focused on addressing this issue before my successor, Andrew Davies, takes up the role on 2 April 2018."

This and other Carillion news releases can be found at www.carillionplc.com.

 

For more information

Kellie McAvoy, Head of Investor Relations, or,

John Denning, Director Group Corporate Affairs, Carillion plc +44 (0) 1902 906333

 

 

 

Teneo Blue Rubicon

Fraser Hardie/Charles Armitstead/Haya Herbert-Burns +44 (0) 207 420 3197

 

Notes to editors

 

Financial covenants

Certain of Carillion's financing arrangements contain financial covenants that leverage (net debt / EBITDA) will be no more than 3.5 times and that interest cover (trading cashflow / net interest pre-IAS 19 charges) will be not less than 3.5 times.

 

Financing arrangements

The relevant financing arrangements are Carillion's senior additional funding facilities, syndicated revolving credit facility, private placement notes, Schuldschein loans, committed bonding lines and committed bilateral facilities.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXFXFEEXFEF
Date   Source Headline
18th Sep 20131:24 pmRNSDirector/PDMR Shareholding
18th Sep 201311:55 amRNSHolding(s) in Company
18th Sep 20137:00 amRNSRe Contract Halton Peel AMC
4th Sep 20139:15 amRNSHalf Yearly Report
22nd Aug 20137:00 amRNSHalf Yearly Report
20th Aug 20131:27 pmRNSHolding(s) in Company
16th Aug 20138:49 amRNSHolding(s) in Company
12th Aug 201311:43 amRNSResignation of Directorship in Another PLC
1st Aug 20133:05 pmRNSHolding(s) in Company
1st Aug 20133:01 pmRNSHolding(s) in Company
30th Jul 20137:00 amRNSRe Contract
4th Jul 20139:00 amRNSHolding(s) in Company
3rd Jul 20137:05 amRNSAwarded contracts by Network Rail worth £122m
3rd Jul 20137:00 amRNSTrading Statement
27th Jun 20137:00 amRNSRe Contract
18th Jun 20134:29 pmRNSDirector/PDMR Shareholding
18th Jun 201310:05 amRNSRe Contract
17th Jun 20137:00 amRNSCarillion secures £130 million contract for Oman
22nd May 20137:00 amRNSRe Contract
9th May 20133:47 pmRNSHolding(s) in Company
9th May 201311:04 amRNSBlocklisting Interim Review
2nd May 201310:48 amRNSResult of AGM
2nd May 20137:00 amRNSRoyal Liverpool Hospital
1st May 201312:30 pmRNSAGM Statement
12th Apr 201310:58 amRNSHolding(s) in Company
11th Apr 201312:02 pmRNSDirector/PDMR Shareholding
8th Apr 201310:42 amRNSHolding(s) in Company
5th Apr 20139:31 amRNSDirector/PDMR Shareholding
25th Mar 201311:00 amRNSDirectorship in Another PLC
18th Mar 201311:03 amRNS2012 Annual Report & Accounts and 2013 AGM Notice
27th Feb 20137:05 amRNSWork winning
27th Feb 20137:00 amRNSPreliminary Results 2012
18th Feb 20139:37 amRNSHolding(s) in Company
30th Jan 20133:04 pmRNSHolding(s) in Company
30th Jan 20133:01 pmRNSHolding(s) in Company
31st Dec 20129:00 amRNSDirector/PDMR Shareholding
19th Dec 201210:45 amRNSDirector/PDMR Shareholding
14th Dec 20129:02 amRNSDirector/PDMR Shareholding
12th Dec 20127:04 amRNSCarillion strategic partner by Lancashire CC £150m
12th Dec 20127:02 amRNSCarillion HM contract in Canada £525m
12th Dec 20127:00 amRNSPre-close Trading Update
12th Dec 20127:00 amRNS49 per cent in Canadian support services £24m
13th Nov 20123:01 pmRNSHolding(s) in Company
13th Nov 20122:58 pmRNSHolding(s) in Company
12th Nov 20122:54 pmRNSBlocklisting Interim Review
9th Nov 201211:24 amRNSDirector/PDMR Shareholding
9th Nov 201210:32 amRNSHolding(s) in Company
2nd Nov 20128:41 amRNSHolding(s) in Company
22nd Oct 20122:37 pmRNSHolding(s) in Company
17th Oct 201211:51 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.